ESC Premium Access

SGLT2 inhibitors and heart failure: expensive diuretics or added value?

Congress Presentation

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
24 presentations
1 follower

3 more presentations in this session

SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad

Speaker: Professor A. Norhammar (Stockholm, SE)

Thumbnail

SGLT2 inhibitors: is the benefit related to renal outcomes?

Speaker: Professor A. Ceriello (Milan, IT)

Thumbnail

Panel discussion: how should cardiologists use SGLT2 inhibitors in clinical practice?

Thumbnail

Access the full session

SGLT2 inhibitors and cardiovascular outcomes

Speakers: Doctor M. Kosiborod, Professor A. Norhammar, Professor A. Ceriello
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

Who should be treated with an SGLT2 inhibitor?

30 August 2021

ESC Premium Access

SGLT2 Inhibitors in heart failure.

29 August 2021

ESC 365 is supported by

logo Novo Nordisk